Mode
Text Size
Log in / Sign up

Prospective study finds no microstructural damage in acute mild traumatic brain injury using MAP-MRINew MRI technique shows little structural change in mild brain injury patients compared to healthy controls

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that acute mTBI may not show detectable microstructural damage on current diffusion MRI techniques.

This prospective observational study examined longitudinal trajectories of MAP-MRI parameters, including PA, NG, RTOP, RTAP, and RTPP, in a cohort of 417 participants comprising 274 patients with acute mTBI and 143 matched controls. The study population included both civilian and military individuals. Follow-up assessments occurred at up to four visits.

Results indicated that MAP-MRI parameter values remained within expected ranges with relatively little variation across visits. When comparing longitudinal trajectories between the mTBI patient group and controls, no significant differences were observed in the diffusion metrics. Additionally, while RPQ-3 and RPQ-13 scores were increased in mTBI patients relative to controls, BESS scores showed no significant difference between the groups. A significant correspondence was noted between MAP-MRI metrics in cortical gray matter, caudate, and pallidum and BESS scores.

Safety data, adverse events, and tolerability were not reported in the study. Key limitations include the absence of significant statistical differences in dMRI parameters, suggesting that while mTBI corresponds to acute post-injury clinical symptoms, the injury may not be severe enough to cause detectable microstructural alterations. The authors note that increased diffusion sensitization combined with improved analysis techniques may be needed to detect such changes. Consequently, acute mTBI (GCS ≥13) may not be detectable with diffusion MRI.

This prospective observational study examined 417 participants, including 274 with acute mild traumatic brain injury and 143 matched healthy controls. The team used a specialized MRI technique to track changes in brain parameters over up to four visits. They also measured balance and cognitive function using standard tests like the BESS and RPQ scores.

The main finding was that the MRI measurements for brain structure did not differ significantly between injured patients and healthy controls. While some functional test scores were higher in the injured group, the imaging itself did not show clear structural damage. This suggests that current diffusion MRI methods might not detect the subtle changes caused by mild injuries.

The researchers noted that the absence of statistical differences in imaging parameters likely means the injuries were not severe enough to cause detectable microstructural alterations. Future studies may need more sensitive techniques to find these changes. Readers should understand that this is an early study and does not prove that mild brain injuries cause no harm, only that current scans cannot see the damage.

What this means for you:
Current MRI scans may not show structural damage in mild brain injuries, suggesting the need for more sensitive testing methods.

Study Details

Sample sizen = 274
EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
BACKGROUNDMild traumatic brain injury (mTBI) is a signature injury in civilian and military populations that remains invisible to detection by conventional radiological methods. Diffusion MRI has been identified as a potential clinical tool for revealing subtle microstructural alterations associated with mTBI. OBJECTIVEThis study evaluates whether a comprehensive and powerful diffusion MRI (dMRI) technique called mean apparent propagator (MAP) MRI can detect sequelae of mTBI. METHODSWe analyzed data from 417 participants of the GE/NFL prospective mTBI study which included 143 matched controls (mean age, 21.9 {+/-} 8.3 years; 76 women) and 274 patients with acute mTBI and GCS [≥]13 (mean age, 21.9 {+/-} 8.5 years; 131 women). All participants underwent MRI exams at up to four visits including structural high-resolution T1W, T2W, FLAIR-T2W, and dMRI, in addition to clinical assessments of post-concussive physical symptoms (RPQ-3), psychosocial functioning and lifestyle symptoms (RPQ-13), and postural stability (BESS). The dMRI data for each subject were co-registered across all visits and analyzed using the MAP-MRI framework to measure and map the distribution of net microscopic displacements of diffusing water molecules in tissue and ultimately compute the microstructural MAP-MRI tissue parameters including propagator anisotropy (PA), Non-Gaussianity (NG), return-to-origin probability (RTOP), return-to-axis probability (RTAP), and return-to-plane probability (RTPP). We quantified voxel-wise and region-of-interest (ROI)-based changes in these parameters across all four visits. RESULTSMAP-MRI parameter values were within the expected ranges and showed relatively little variation across visits. We found no significant differences in the longitudinal trajectories of these parameters between mTBI patients and controls. At acute post-injury timepoints, RPQ-3 and RPQ-13 scores were increased in mTBI patients relative to controls, while BESS scores were not significantly different between groups. Analysis of dMRI metrics and clinical mTBI markers showed significant correspondence between MAP-MRI metrics in cortical gray matter, caudate and pallidum and BESS scores. CONCLUSIONWe developed and tested a state-of-the-art quantitative image processing pipeline for sensitive analysis and detection of subtle tissue changes in longitudinal clinical diffusion MRI data. The absence of a significant statistical difference between populations in the dMRI parameters in this study suggests that the mTBI corresponded to acute post-injury clinical symptoms but that the injury was not severe enough to cause detectable microstructural damage/alterations, and that increased diffusion sensitization combined with improved analysis techniques may be needed. CLINICAL IMPACTThese findings suggest that acute mTBI (GCS[≥]13) may not be detectable with diffusion MRI. TRIAL REGISTRATIONClinicalTrials.gov NCT02556177
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.